A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis

Published:2019-03 Issue: Volume:149 Page:47-63
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Farah Daniela,Leme Graziella Malzoni,Eliaschewitz Freddy Goldberg,Fonseca Marcelo Cunio Machado

Funder

Takeda Pharmaceuticals

Takeda Distribuidora Ltda.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference65 articles.

1. World Health Organization. Diabetes: fact sheet; 2017. http://www.who.int/mediacentre/factsheets/fs312/en/ [accessed Nov 6, 2017].

2. Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas;Deacon;DiabetesObes Metab,2016

3. Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: management of type 2 diabetes mellitus;Conlin;Ann Intern Med,2017

4. consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2018 executive summary;Garber;Endocr Pract,2018

5. Efficacy and tolerability of sitagliptin compared with glimepiride in elderly patients with type 2 diabetes mellitus and inadequate glycemic control: a randomized, double-blind non-inferiority trial;Hartley;Drugs Aging,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of dipeptidyl peptidase 4 inhibitors on health-related quality of life in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;Quality of Life Research;2024-08-03

2. New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study;European Heart Journal - Cardiovascular Pharmacotherapy;2023-11-14

3. New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: A Chinese population-based cohort study;2023-07-05

4. Cardiovascular Events and Heart Failure in Patients with Type 2 Diabetes Treated with Dipeptidyl Peptidase-4 Inhibitors: An Update Systematic Review and Meta-Analysis;2023

5. Mechanisms of drugs in the treatment of type 2 diabetes mellitus;Chinese Medical Journal;2022-11-07